Inhibitor Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2012 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Inhibitor Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2012 to 2023.
  • Inhibitor Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was 0 USD/shares.
  • Inhibitor Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.02 USD/shares, a 167% decline year-over-year.
  • Inhibitor Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -0.02 USD/shares, a 167% decline from 2022.
  • Inhibitor Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was 0.03 USD/shares.
  • Inhibitor Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was 0 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 -167% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $0.03 +$0.03 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2013 $0 $0 -1100% Jan 1, 2013 Dec 31, 2013 10-K 2014-04-15
2012 $0.01 Jan 1, 2012 Dec 31, 2012 10-K 2014-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.